243 related articles for article (PubMed ID: 29408170)
1. Acute phase reactant, Pentraxin 3, as a novel marker for the diagnosis of rheumatoid arthritis.
Sharma A; Khan R; Gupta N; Sharma A; Zaheer MS; Abbas M; Khan SA
Clin Chim Acta; 2018 May; 480():65-70. PubMed ID: 29408170
[TBL] [Abstract][Full Text] [Related]
2. Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies.
Weitoft T; Larsson A; Saxne T; Manivel VA; Lysholm J; Knight A; Rönnelid J
Scand J Rheumatol; 2017 Sep; 46(5):346-352. PubMed ID: 27973973
[TBL] [Abstract][Full Text] [Related]
3. Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA).
Luchetti MM; Piccinini G; Mantovani A; Peri G; Matteucci C; Pomponio G; Fratini M; Fraticelli P; Sambo P; Di Loreto C; Doni A; Introna M; Gabrielli A
Clin Exp Immunol; 2000 Jan; 119(1):196-202. PubMed ID: 10606983
[TBL] [Abstract][Full Text] [Related]
4. Serum pentraxin 3 levels are negatively associated with carotid intima media thickness in non-obese rheumatoid arthritis patients.
Kahlow BS; Petisco R; Skare TL; Goeldner I; Nisihara RM; Messias-Reason IJ
Int J Cardiol; 2016 Oct; 221():298-301. PubMed ID: 27404695
[TBL] [Abstract][Full Text] [Related]
5. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation.
Fazzini F; Peri G; Doni A; Dell'Antonio G; Dal Cin E; Bozzolo E; D'Auria F; Praderio L; Ciboddo G; Sabbadini MG; Manfredi AA; Mantovani A; Querini PR
Arthritis Rheum; 2001 Dec; 44(12):2841-50. PubMed ID: 11762945
[TBL] [Abstract][Full Text] [Related]
6. Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response.
Boutet MA; Nerviani A; Lliso-Ribera G; Leone R; Sironi M; Hands R; Rivellese F; Del Prete A; Goldmann K; Lewis MJ; Mantovani A; Bottazzi B; Pitzalis C
Front Immunol; 2021; 12():686795. PubMed ID: 34248970
[TBL] [Abstract][Full Text] [Related]
7. Serum and synovial fluid concentrations of cold-inducible RNA-binding protein in patients with rheumatoid arthritis.
Yoo IS; Lee SY; Park CK; Lee JC; Kim Y; Yoo SJ; Shim SC; Choi YS; Lee Y; Kang SW
Int J Rheum Dis; 2018 Jan; 21(1):148-154. PubMed ID: 27315340
[TBL] [Abstract][Full Text] [Related]
8. Levels of pentraxin-3 in gingival crevicular fluid and plasma in periodontal health and disease.
Pradeep AR; Kathariya R; Raghavendra NM; Sharma A
J Periodontol; 2011 May; 82(5):734-41. PubMed ID: 21080790
[TBL] [Abstract][Full Text] [Related]
9. Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study.
Asanuma YF; Aizaki Y; Noma H; Yokota K; Matsuda M; Kozu N; Takebayashi Y; Nakatani H; Hasunuma T; Kawai S; Mimura T
Mod Rheumatol; 2020 Nov; 30(6):959-966. PubMed ID: 31615315
[No Abstract] [Full Text] [Related]
10. Increased Circulating Pentraxin 3 Levels in Patients with Rheumatoid Arthritis: A Meta-analysis.
Guan SY; Chen Y; Shao M; Yang H; Xu W; Shuai Z; Zhao H; Zhao D; Pan F
Curr Pharm Des; 2022; 28(27):2260-2269. PubMed ID: 35708089
[TBL] [Abstract][Full Text] [Related]
11. Pentraxin-3 as a local inflammatory marker in chronic spontaneous urticaria.
Kasperska-Zajac A; Grzanka A; Misiolek M; Mazur B; Machura E
Cytokine; 2015 Dec; 76(2):566-568. PubMed ID: 25982553
[TBL] [Abstract][Full Text] [Related]
12. Ferritin correlates with C-reactive protein and acute phase serum amyloid A in synovial fluid, but not in serum.
Kumon Y; Suehiro T; Nishiya K; Hashimoto K; Nakatani K; Sipe JD
Amyloid; 1999 Jun; 6(2):130-5. PubMed ID: 10439120
[TBL] [Abstract][Full Text] [Related]
13. Goeckerman's therapy for psoriasis with special reference to serum pentraxin 3 level.
Ctirad A; Lenka B; David P; Zdenek F; Kveta H; Karel E; Jan K
Int J Dermatol; 2008 Oct; 47(10):1011-4. PubMed ID: 18986345
[TBL] [Abstract][Full Text] [Related]
14. Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia.
Kao SJ; Yang HW; Tsao SM; Cheng CW; Bien MY; Yu MC; Bai KJ; Yang SF; Chien MH
Clin Chem Lab Med; 2013 Apr; 51(4):907-13. PubMed ID: 23152412
[TBL] [Abstract][Full Text] [Related]
15. Blood monocyte chemotactic protein-1 (MCP-1) and adapted disease activity Score28-MCP-1: favorable indicators for rheumatoid arthritis activity.
Liou LB; Tsai WP; Chang CJ; Chao WJ; Chen MH
PLoS One; 2013; 8(1):e55346. PubMed ID: 23383162
[TBL] [Abstract][Full Text] [Related]
16. Estimation of pentraxin-3 levels in the gingival tissues of chronic and aggressive periodontitis participants: an in vivo study.
Lakshmanan R; Jayakumar ND; Sankari M; Padmalatha O; Varghese S
J Periodontol; 2014 Feb; 85(2):290-7. PubMed ID: 23701480
[TBL] [Abstract][Full Text] [Related]
17. PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
Ramirez GA; Rovere-Querini P; Blasi M; Sartorelli S; Di Chio MC; Baldini M; De Lorenzo R; Bozzolo EP; Leone R; Mantovani A; Manfredi AA; Tombetti E
Front Immunol; 2019; 10():1135. PubMed ID: 31191526
[TBL] [Abstract][Full Text] [Related]
18. Alveolar pentraxin 3 as an early marker of microbiologically confirmed pneumonia: a threshold-finding prospective observational study.
Mauri T; Coppadoro A; Bombino M; Bellani G; Zambelli V; Fornari C; Berra L; Bittner EA; Schmidt U; Sironi M; Bottazzi B; Brambilla P; Mantovani A; Pesenti A
Crit Care; 2014 Oct; 18(5):562. PubMed ID: 25314919
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes.
Satomura K; Torigoshi T; Koga T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Yamasaki S; Kawakami A; Aiba Y; Nakamura M; Komori A; Sato J; Ishibashi H; Motokawa S; Migita K
Mod Rheumatol; 2013 Jan; 23(1):28-35. PubMed ID: 22447522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
